Molecular Partners AG (ADR)
General ticker "MOLN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $139.6M (TTM average)
Molecular Partners AG (ADR) follows the US Stock Market performance with the rate: 26.7%.
Estimated limits based on current volatility of 1.3%: low 4.16$, high 4.26$
Factors to consider:
- Total employees count: 163 as of 2021
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.92$, 6.80$]
- 2026-12-31 to 2027-12-31 estimated range: [2.67$, 6.33$]
Financial Metrics affecting the MOLN estimates:
- Positive: with PPE of -2.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -39.93 <= 0.07
- Positive: Shareholder equity ratio, % of 78.68 > 64.25
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 56.52 > -0.65
Short-term MOLN quotes
Long-term MOLN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CHF7.04MM | CHF4.97MM | CHF0.00MM |
| Operating Expenses | CHF68.15MM | CHF66.19MM | CHF58.12MM |
| Operating Income | CHF-61.11MM | CHF-61.22MM | CHF-58.12MM |
| Non-Operating Income | CHF-0.88MM | CHF7.18MM | CHF-3.52MM |
| Interest Expense | CHF0.05MM | CHF0.03MM | CHF0.02MM |
| R&D Expense | CHF48.78MM | CHF48.60MM | CHF40.19MM |
| Income(Loss) | CHF-61.98MM | CHF-54.04MM | CHF-61.65MM |
| Taxes | CHF0.00MM | CHF0.00MM | CHF0.00MM |
| Profit(Loss)* | CHF-61.98MM | CHF-54.04MM | CHF-61.65MM |
| Stockholders Equity | CHF176.43MM | CHF141.64MM | CHF80.33MM |
| Assets | CHF198.35MM | CHF158.53MM | CHF102.11MM |
| Operating Cash Flow | CHF-59.01MM | CHF-59.25MM | CHF-51.26MM |
| Capital expenditure | CHF0.57MM | CHF0.72MM | CHF0.71MM |
| Investing Cash Flow | CHF44.64MM | CHF40.49MM | CHF72.55MM |
| Financing Cash Flow | CHF-1.17MM | CHF14.43MM | CHF-1.15MM |
| Earnings Per Share** | CHF-1.89 | CHF-1.59 | CHF-1.65 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.